Merck & Co., Inc: Arthritis, Rheumatoid trials
The registry lists 30 Arthritis, Rheumatoid studies with Merck & Co., Inc as lead sponsor. 2 are open to participants now and 18 have results posted.
Phase 1 3Phase 2 10Phase 3 5Phase 4 2No phase 10(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- A Clinical Trial of MK-8690 in Participants With Rheumatoid Arthritis (MK-8690-004)Not yet recruitingNCT07895524Phase 2
- A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004)RecruitingNCT07363590Phase 1
- A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter Trial to Evaluate the Safety, Tolerability, and Efficacy of MK-8457 in Participants With Rheumatoid Arthritis (MK-8457-010)TerminatedNCT01651936Phase 2Results posted
- Safety and Efficacy of MK-8457 and Methotrexate (MTX) in Participants With Active Rheumatoid Arthritis Despite MTX Therapy (P08683, MK-8457-008)TerminatedNCT01569152Phase 2Results posted
- A Study of the Pharmacokinetics and Safety of MK-8808 (MK-8808-002)TerminatedNCT01390441Phase 1Results posted
- A Study to Investigate the Use of Golimumab (Simponi®) in Participants With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis (P06554)CompletedNCT01313858Results posted
- A Study to Evaluate the Effectiveness of Infliximab and Changes in Hand and Wrist Magnetic Resonance Imaging (MRI) in Participants With Active Rheumatoid Arthritis (RA) (P08136)CompletedNCT01313520Phase 2Results posted
- Subcutaneous Golimumab (GLM) Plus DMARDs for Rheumatoid Arthritis, Followed by Intravenous/Subcutaneous GLM Strategy (P06129 AM2)CompletedNCT00975130Phase 3Results posted
- Remicade Safety Line (Study P03236)(COMPLETED)CompletedNCT00748826Results posted
- A Study of the Effects of Oral Prednisone in Patients With Rheumatoid Arthritis (MK0000-088)CompletedNCT00746512Phase 1Results posted
- A Feasibility Study Exploring the Effect of Remicade on the Disease Activity in RA Patients (Study P05417)CompletedNCT00741104Results posted
- A Trial of Anti-TNF Chimeric Monoclonal Antibody (cA2) in Korean Patients With Active Rheumatoid Arthritis Despite Methorexate (Extension Part)(Study P05645)(COMPLETED)CompletedNCT00732875Phase 3Results posted
- Post Marketing Surveillance Study of Remicade in Patients With Chronic Inflammatory Diseases (P04840)CompletedNCT00727298Results posted
- Real Life Dosing of Remicade for Rheumatoid Arthritis in Austria Monitored Over 9 Infusions (Study P03756)(COMPLETED)CompletedNCT00725621Results posted
- Safety and Effectiveness of Infliximab in Slovakia When Used for Rheumatoid Arthritis (Study P04741)(COMPLETED)CompletedNCT00724243Results posted
- A Study to Observe Characteristics of Rheumatoid Arthritis in Patients Using Infliximab (Study P04250)CompletedNCT00705289Results posted
- Study Evaluating the Analgesic Efficacy and Safety of ADL5859 in Participants With Rheumatoid ArthritisCompletedNCT00626275Phase 2Results posted
- Induction of Remission in RA Patients at Low Disease Activity by Additional Infliximab Therapy (Study P04644AM1) (TERMINATED)TerminatedNCT00521924Phase 3Results posted
- Re³ (Re-Cube: Retain Remicade® Response)(Study P04249AM3)TerminatedNCT00394589Phase 3Results posted
- A Study of a Novel Investigational Drug in Rheumatoid Arthritis Patients (MK-0873-012)(COMPLETED)CompletedNCT00132769Phase 2Results posted
- A Clinical Study of Tulisokibart (MK-7240) to Treat Rheumatoid Arthritis (RA) (MK-7240-014)Active, not recruitingNCT07176390Phase 2
- Assessment of the Disease Severity and Treatment Patterns of Rheumatoid Arthritis in Eastern Europe, Middle East and North African Countries (P08167)WithdrawnNCT01313871
- Efficacy of Remicade in the Treatment of Active Rheumatoid Arthritis Despite Methotrexate (Study P03027)CompletedNCT00794898Phase 4
- The Canadian Follow-up Program for the ATTRACT Study (P04868)(TERMINATED)TerminatedNCT00748930
- A Study of Immune Cells in Patients With Rheumatoid Arthritis During Different Types of Anti-TNF Alpha Treatments (Study P05521)WithdrawnNCT00724672
- 12-Week No-Rofecoxib Plus Aspirin Endoscopy Study (0782-003)TerminatedNCT00543465Phase 2
- Efficacy, Tolerability and Safety Study in Rheumatoid Arthritis (0812-008)CompletedNCT00542022Phase 2
- Efficacy and Safety Study of MK0359 in Patients With Arthritis (0359-017)CompletedNCT00482417Phase 2
- A Placebo-Controlled, Double-Blinded, Randomized Trial of Remicade in Korean Patients With Rheumatoid Arthritis Despite Methotrexate (Study P04280)(COMPLETED)CompletedNCT00202852Phase 3
- A Study of Rofecoxib Versus Naproxen in the Treatment of Chinese Patient With Rheumatoid Arthritis (0966-231)CompletedNCT00157872Phase 4